A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)

por Rivas, Dylan R., Dela Cerna, Mark Vincent C., Smith, Caroline N., Sampathi, Shilpa, Patty, Blaine G., Lee, Donghan, Blackburn, Jessica S.
Publicado 2021